Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer - Wikidata - awgldk - TriplyDB

Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer

Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer

http://www.wikidata.org/entity/Q35615320

about

Genomic Copy Number Variations in the Genomes of Leukocytes Predict Prostate Cancer Clinical Outcomes.Emerging concepts in liquid biopsies Common Genetic Variation in CYP17A1 and Response to Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer.Copy number variations in urine cell free DNA as biomarkers in advanced prostate cancer.Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer.Novel agents for castration-resistant prostate cancer: Early experience and beyond.Molecular biomarkers to guide precision medicine in localized prostate cancer.Non-invasive detection of genome-wide somatic copy number alterations by liquid biopsies Metabolomic Biomarkers of Prostate Cancer: Prediction, Diagnosis, Progression, Prognosis, and Recurrence.Cell-free DNA copy number variations in plasma from colorectal cancer patients.The Mutational Landscape of Gastrointestinal Malignancies as Reflected by Circulating Tumor DNA.Utility of cell-free nucleic acid and circulating tumor cell analyses in prostate cancer.MALBAC-based chromosomal imbalance analysis: a novel technique enabling effective non-invasive diagnosis and monitoring of bladder cancer.Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death

P2860

Q35752335-44C444C2-2F9D-4A9A-9D04-1D3FE5577251 Q36337259-936B436F-57E7-4B2C-859F-1BA0B38E4593 Q37134564-9D80AA6B-DE1B-4FBF-9B76-89AB8A5F51B2 Q37392579-62894C8C-D6DE-4A9F-A5E6-00C0DC2A5F45 Q37536958-3FAB3789-A685-402A-8CEA-491C8B5E4F09 Q38574684-6C7D21FF-48C8-44F9-9950-C11BB06469AD Q38668635-A730DB51-2031-480F-AB7B-0A24CF60F388 Q38700222-223F8F3E-D57A-4EF3-9AC5-C6F05F2AE08F Q38838580-A056CC06-7B42-4991-93C9-5C1EDE2A0C9C Q41194527-107F554C-9B89-4523-A16E-35BFB1D63B18 Q50042439-C261AF73-B03A-465E-8E19-B48B967B9385 Q55343494-D942DE7C-5E4C-4F16-AA4E-914978EEEA96 Q55425955-940D1032-D16E-4B0A-86F8-8635B6FDEEF0 Q58764394-B49C0E9D-36CF-4DC8-A85A-8F5562AC5FCD

P2860

Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer

http://www.wikidata.org/entity/Q35615320

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Plasma genetic and genomic abn ...... me in advanced prostate cancer

@ast

Plasma genetic and genomic abn ...... me in advanced prostate cancer

@en

type

label

Plasma genetic and genomic abn ...... me in advanced prostate cancer

@ast

Plasma genetic and genomic abn ...... me in advanced prostate cancer

@en

prefLabel

Plasma genetic and genomic abn ...... me in advanced prostate cancer

@ast

Plasma genetic and genomic abn ...... me in advanced prostate cancer

@en

P1433

Q35615320-2908790F-08CC-4B6C-BA3A-2F332FE75BDB

P1476

Q35615320-5276B2DA-5CCB-4EE9-B57B-820CD29C4C85

P2093

Q35615320-24294BF7-8101-47F1-83AE-0E52AB358D97

Q35615320-48D6EFF8-8EA6-43AB-BDC5-BF6B53AA5825

Q35615320-4F98C672-C026-4C1B-A6BB-31A9BF58D1DD

Q35615320-51D1F74C-B01B-4D98-A672-B3310BFA4D3F

Q35615320-64376E64-6772-40B3-8223-BB145A9E5255

Q35615320-6D5D370C-C838-4361-852B-7701055EAF65

Q35615320-94B2BA2A-EFE8-43B7-890D-F5B4997C2776

Q35615320-9C2173F4-520E-4293-875D-BE5EA0170F33

Q35615320-A0897A7A-A82E-4CB7-BB9F-93586447D5C0

Q35615320-B018A3F3-D288-4E98-B43A-531648DD8DB8

P2860

Q35615320-02988DE9-2E38-402D-B181-1672F4A558FF

Q35615320-07A18E36-28F2-47A4-B6EA-709A75DCD0C7

Q35615320-0C93CC09-684C-4C60-90CD-C739B83715EE

Q35615320-0D6EB6F3-0112-4FC2-A6BA-1FF13B62E40F

Q35615320-14AB91D1-A83C-47B0-BBCA-FE3E8B128BB8

Q35615320-19F8410C-DCBD-4AB3-A333-FB22A6535725

Q35615320-1C0E25AE-9B51-416F-AE34-35B6FD756520

Q35615320-1C34920A-73D7-4E0E-8186-2EF924CCEC12

Q35615320-22E229B3-1E61-4FAB-B0EE-AFE7A8D6C948

Q35615320-24047EE5-7EA2-4491-9A08-07FC40A74EFC

P304

Q35615320-253781BE-B353-4FBB-A2AA-4EB165365726

P31

Q35615320-E96228D0-1CE2-4C67-8C62-B43FF8ADC2FE

P356

Q35615320-837863AB-8A13-4B05-B111-BF44F4A26208

P407

Q35615320-67DA17B4-8677-4A03-A085-074C780E49E0

P433

Q35615320-84D7961F-8A04-429B-BD6D-6123FBC2213F

P478

Q35615320-DBF27E8C-99D3-4FE8-AF4E-577BE2319872

P577

Q35615320-293EC1F8-F78F-432C-93C1-AD00805B2102

P698

Q35615320-87664E66-F9B3-43B6-BF25-B18900FB6C94

P932

Q35615320-43EBCBCF-0189-40BB-96FE-1ECFBD41F183

P356

ONCOTARGET.3845

P1433

P1476

Plasma genetic and genomic abn ...... me in advanced prostate cancer

@en

P2093

Adam Lee

http://www.w3.org/2001/XMLSchema#string

Chiang-Ching Huang

http://www.w3.org/2001/XMLSchema#string

Debashis Nandy

http://www.w3.org/2001/XMLSchema#string

Deepak Kilari

http://www.w3.org/2001/XMLSchema#string

Elizabeth Worthey

http://www.w3.org/2001/XMLSchema#string

Howard Jacob

http://www.w3.org/2001/XMLSchema#string

Liang Wang

http://www.w3.org/2001/XMLSchema#string

Manish Kohli

http://www.w3.org/2001/XMLSchema#string

Meijun Du

http://www.w3.org/2001/XMLSchema#string

Michael R Tschannen

http://www.w3.org/2001/XMLSchema#string

P2860

Liquid biopsies: genotyping circulating tumor DNA

Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing

Analysis of circulating tumor DNA to monitor metastatic breast cancer

Detection of circulating tumor DNA in early- and late-stage human malignancies

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

New developments in the medical management of prostate cancer.

Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.

Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer.

Liquid biopsy: monitoring cancer-genetics in the blood.

Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade.

P304

16411-16421

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.3845

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25915538

http://www.w3.org/2001/XMLSchema#string

P932

4599278

http://www.w3.org/2001/XMLSchema#string